TCW Group Inc. Purchases 1,709 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

TCW Group Inc. increased its position in Henry Schein, Inc. (NASDAQ:HSIC) by 6.5% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 28,077 shares of the company’s stock after buying an additional 1,709 shares during the quarter. TCW Group Inc.’s holdings in Henry Schein were worth $1,943,000 at the end of the most recent reporting period.

Several other hedge funds also recently bought and sold shares of HSIC. Versant Capital Management Inc boosted its holdings in Henry Schein by 274.6% in the 4th quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock worth $32,000 after buying an additional 335 shares during the period. Venturi Wealth Management LLC boosted its holdings in shares of Henry Schein by 3,347.1% during the 4th quarter. Venturi Wealth Management LLC now owns 586 shares of the company’s stock valued at $41,000 after purchasing an additional 569 shares during the last quarter. Quent Capital LLC boosted its holdings in shares of Henry Schein by 91.2% during the 4th quarter. Quent Capital LLC now owns 677 shares of the company’s stock valued at $47,000 after purchasing an additional 323 shares during the last quarter. City State Bank bought a new position in shares of Henry Schein during the 4th quarter valued at about $55,000. Finally, Farther Finance Advisors LLC boosted its holdings in shares of Henry Schein by 58.9% during the 3rd quarter. Farther Finance Advisors LLC now owns 933 shares of the company’s stock valued at $68,000 after purchasing an additional 346 shares during the last quarter. Institutional investors own 96.62% of the company’s stock.

Analysts Set New Price Targets

Several research analysts have commented on the stock. StockNews.com raised shares of Henry Schein from a “sell” rating to a “hold” rating in a report on Thursday, November 7th. Bank of America raised shares of Henry Schein from an “underperform” rating to a “buy” rating and increased their price target for the company from $69.00 to $84.00 in a report on Monday, January 6th. Barrington Research increased their price target on shares of Henry Schein from $82.00 to $90.00 and gave the company an “outperform” rating in a report on Thursday, January 30th. Wells Fargo & Company assumed coverage on shares of Henry Schein in a report on Friday, February 14th. They issued an “equal weight” rating and a $80.00 price target for the company. Finally, Jefferies Financial Group increased their price target on shares of Henry Schein from $77.00 to $80.00 and gave the company a “hold” rating in a report on Thursday, January 23rd. Eight investment analysts have rated the stock with a hold rating, five have assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $80.09.

Henry Schein Stock Performance

Shares of NASDAQ:HSIC opened at $77.64 on Tuesday. The firm has a market cap of $9.68 billion, a PE ratio of 31.95, a price-to-earnings-growth ratio of 2.13 and a beta of 0.91. The firm’s 50 day simple moving average is $74.19 and its 200-day simple moving average is $72.38. Henry Schein, Inc. has a one year low of $63.67 and a one year high of $82.63. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.